ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Remadi, J. P.
Right arrow Articles by Tribouilloy, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Remadi, J. P.
Right arrow Articles by Tribouilloy, C.
Related Collections
Right arrow Valve disease

Ann Thorac Surg 2007;83:1295-1302
© 2007 The Society of Thoracic Surgeons

Original Articles: Cardiovascular

Predictors of Death and Impact of Surgery in Staphylococcus aureus Infective Endocarditis

Jean Paul Remadi, MDa, Gilbert Habib, MDb, Georges Nadji, MDa, Amel Brahim, MDa, Franck Thuny, MDb, Jean Paul Casalta, MDb, Marcel Peltier, MDa, Christophe Tribouilloy, MD, PhDa,*

a Department of Cardiovascular Disease, INSERM, ERI-12 CHU, Amiens, France
b Department of Cardiology, La Timone Hospital, Marseille, France

Accepted for publication September 28, 2006.

* Address correspondence to Dr Tribouilloy, INSERM, ERI-12 CHU, Hôpital Sud, Avenue René Laënnec, 80054 Amiens, Cédex 1, France (Email: tribouilloy.christophe{at}chuamiens.fr).

Background: We studied a large cohort of adults with Staphylococcus aureus infective endocarditis to evaluate the predictors of outcome and to establish whether early surgery is associated with reduced mortality.

Methods: The study prospectively enrolled 116 consecutive patients with definite S aureus infective endocarditis, according to Duke criteria and examined by transthoracic and transesophageal echocardiography.

Results: The in-hospital mortality rate was 26%, and the 36-month survival rate was 57% ± 5%. Multivariate analyses identified comorbidity index, congestive heart failure, severe sepsis, prosthetic valve infective endocarditis, and major neurologic events as predictors of in-hospital mortality; severe sepsis and comorbidity index as predictors of overall mortality; and the comorbidity index as a predictor of late mortality. In unadjusted analyses, early surgery performed in 47% of patients was associated with lower in-hospital mortality (16% versus 34%; p = 0.034) and with better 36-month survival (77% ± 6% versus 39% ± 7%; p < 0.001). After adjustment of baseline variables related to mortality, early surgery remained associated with reduced overall mortality.

Conclusions: Prognosis of S aureus infective endocarditis remains poor, related to the comorbidities, presence of congestive heart failure, severe sepsis, major neurologic events, and prosthetic valve. Early surgery is independently associated with reduced overall mortality and should be considered in selected cases to improve the outcome.




This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
S. H. Rahimtoola
The Year in Valvular Heart Disease.
J. Am. Coll. Cardiol., February 19, 2008; 51(7): 760 - 770.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by The Society of Thoracic Surgeons.